Jennifer True
Vice President of Quality at Meitheal Pharmaceuticals, Inc.
Professional Overview
Jennifer True is an accomplished quality assurance and regulatory affairs executive with over 20 years of experience in the pharmaceutical industry. As the Vice President of Quality at Meitheal Pharmaceuticals, Inc., she oversees all aspects of quality control, quality assurance, and compliance for the company's drug manufacturing operations.
Experience Summary
Current Role
In her current role as Vice President of Quality, Jennifer is responsible for developing and implementing comprehensive quality management systems to ensure the consistent production of safe, effective, and compliant pharmaceutical products. She leads a team of quality professionals and works closely with cross-functional departments to drive continuous improvement and maintain the highest standards of quality throughout the organization.
Career Progression
Jennifer's career in the pharmaceutical industry began at Baxter, where she held various research and quality associate roles. She then transitioned to Catalent, where she gained experience as a CAPA Specialist and Senior Regulatory Affairs Specialist. Jennifer subsequently joined Sagent Pharmaceuticals, progressing from a QA Specialist to a QA Manager role. In 2017, she joined Meitheal Pharmaceuticals as the Director of Quality, and was promoted to her current position of Vice President of Quality in 2024.
Academic Background
Jennifer holds a Bachelor of Science degree in Biology from the University of Illinois at Urbana-Champaign, with a focus on Molecular and Cellular Biology. She has also completed various industry-specific training programs and certifications in quality management, regulatory affairs, and pharmaceutical manufacturing.
Areas of Expertise
- Quality management systems and quality assurance
- Pharmaceutical manufacturing processes and operations
- Regulatory compliance and auditing
- Lean Six Sigma methodologies
- Cross-functional team leadership and collaboration
Professional Impact
During her tenure at Meitheal Pharmaceuticals, Jennifer has spearheaded several key initiatives that have positively impacted the company's quality and compliance performance. She led the implementation of a robust quality management system that resulted in a significant reduction in product recalls and customer complaints, while also improving on-time delivery and overall operational efficiency.
Jennifer's expertise and leadership have been instrumental in maintaining Meitheal Pharmaceuticals' strong regulatory standing, with the company consistently receiving positive outcomes from FDA inspections and audits. She is also actively involved in industry organizations, where she contributes her knowledge and insights to the advancement of quality standards in the pharmaceutical sector.
Conclusion
With her extensive experience, technical expertise, and proven track record of driving quality improvements, Jennifer True is a valuable asset to Meitheal Pharmaceuticals. As the Vice President of Quality, she continues to play a crucial role in ensuring the company's commitment to product safety, regulatory compliance, and operational excellence.
